Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-23-039710
Filing Date
2023-08-14
Accepted
2023-08-14 16:59:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 ny20010067x1_s3.htm S-3 347921
2 EXHIBIT 5.1 ny20010067x1_ex5-1.htm EX-5.1 13519
3 EXHIBIT 23.1 ny20010067x1_ex23-1.htm EX-23.1 1915
4 EXHIBIT 23.2 ny20010067x1_ex23-2.htm EX-23.2 2930
5 FILING FEES TABLE ny20010067x1_ex107.htm EX-FILING FEES 24167
  Complete submission text file 0001140361-23-039710.txt   391749
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273977 | Film No.: 231171676
SIC: 2834 Pharmaceutical Preparations